Agilent Technologies Inc (NYSE:A)

Delayed Data
As of Dec 06
 +0.02 / +0.02%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Contact Information

Agilent Technologies, Inc.
5301 Stevens Creek Boulevard
Santa Clara California 95051
P:(408) 553-2424
Investor Relations:



Mutual fund holders56.73%
Other institutional33.57%
Individual stakeholders1.57%

Top Executives

Michael R. McMullenPresident, Chief Executive Officer & Director
Robert W. McMahonChief Financial Officer & Senior Vice President
Katharine KnobilChief Medical Officer
John KohlChief Information Officer & Senior Vice President
Michael TangSecretary, Senior Vice President & General Counsel